Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Alpha Diarylmethyl Ketone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115925527A details a Ru-catalyzed hydroarylation for alpha-diarylmethyl ketones, offering high selectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN115925527B details a Ru-catalyzed method for high-purity API intermediate synthesis, offering significant cost reduction and supply chain reliability for global buyers.